Pneumothorax pathophysiology

Jump to navigation Jump to search

Pneumothorax Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumothorax from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography/Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumothorax pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumothorax pathophysiology

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumothorax pathophysiology

CDC on Pneumothorax pathophysiology

Pneumothorax pathophysiology in the news

Blogs on Pneumothorax pathophysiology

Directions to Hospitals Treating Pneumothorax

Risk calculators and risk factors for Pneumothorax pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Feham Tariq, MD [2], Hamid Qazi, MD, BSc [3]

Overview

Pneumothorax is air in the pleural space under pressure resulting in lung collapse.The pathophysiology of each type depends on the underlying disease/etiology. Primary spontaneous pneumothorax most commonly results from the bleb (small air-filled lesions under pleural surface) rupture allowing the air to leak into the pleural space. A subclass of primary spontaneous pneumothorax is isolated familial primary spontaneous pneumothorax which is genetically associated with folliculin gene mutation. Secondary spontaneous pneumothorax occurs subsequent to underlying lung pathology such as obstructive lung disease, cystic fibrosis, diffuse parenchymal lung disease and lung cancer. In tension pneumothorax, the underlying pathophysiology most commonly is chest trauma forming a one-way valve in the pleura whereby air enters the pleural space when the pleural pressure is negative during inspiration. Pneumothorax can also result from several interventional procedures which cause penetrating or non-penetrating injury to the pleura resutling in abrupt increase in the alveolar pressure and hence, lead to alveolar rupture forming a communication with the pleura.

Pathophysiology

Anatomy and physiology of the thoracic cavity

The normal anatomy and physiology of thoracic cavity is as follows:

  • On either side of the cavity, a pleural membrane covers the outside surface of the lung (visceral pleura) and also lines the inside of the chest wall (parietal pleura).
  • The two layers are separated by a small amount of lubricating serous fluid known as the pleural fluid.
  • The lungs are fully inflated within the cavity as the pressure inside the airways is higher than the pressure inside the pleural space.
  • The inhaled air does not enter the pleural space as there is no natural connections between them as well as the pressure of gases in the blood stream is too low for them to be forced into the pleural space.
  • The pleural pressure is negative with respect to atmospheric pressure during spontaneous breathing.
  • Air can enter the pleural space through the following mechanisms:[4][5][6]
Pneumothorax Source:By National Heart Lung and Blood Institute, via Wikimedia Commons


Pathogenesis

The pathophysiology of pneumothorax depends on the underlying disease causing it.

Primary spontaneous pneumothorax

  • The most common underlying pathology of primary spontaneous pneumothorax is an apical subpleural bleb (small air-filled lesions under the pleural surface).[7]
  • In addition, smoking causes inflammation and obstruction of the small airways, which is responsible for the increased risk of primary spontaneous pneumothorax in smokers.

Secondary spontaneous pneumothorax

  • Pneumothorax due to underlying lung disease is secondary spontaneous pneumothorax.

Tension pneumothorax

  • The disruption occurs when a one-way valve forms, allowing air inflow into the pleural space, and prohibiting air outflow.
  • The volume of this nonabsorbable intrapleural air increases with each inspiration.
  • As a result, pressure rises within the affected hemithorax; ipsilateral lung collapses and causes hypoxia.
  • Further pressure causes the mediastinum shift toward the contralateral side and compresses both, the contralateral lung and the vasculature entering the right atrium of the heart.
  • This leads to worsening hypoxia and compromised venous return.

Iatrogenic pneumothorax

Following procedures commonly cause iatrogenic pneumothorax:[10][11]

Mechanism of injury:

Genetics

Genetic association of familial primary sponatneous pneumothorax

The genetic association of familial primary sponatneous pneumothorax is as follows:[15][16][17][18][19][20]

  • Primary spontaneous pneumothorax can result as a mutation in the FLCN (folliculin) gene.
  • This gene codes for a protein called folliculin.
  • It is produced by the cells lining the alveoli of the lung.
  • Folliculin is found in the connective tissue cells that allow the lungs to contract and expand while breathing.
  • It plays a role in repairing the lung tissue after damage.
  • Nonsense mutation in the folliculin gene results in isolated familial sponataneous primary pneumothorax.[21]
  • Altered folliculin protein can trigger the inflammatory process within the lung tissue that can alter and damage the tissue, resulting in blebs formation.

Associated Conditions

Pneumothorax is associated with the following conditions:[22][23]

Genetics

A defect in the gene TGFβR2 on chromosome 3, a receptor protein of TGFβ, has also been related to Marfan syndrome.[24] Marfan syndrome can often be confused with Loeys-Dietz syndrome, a similar connective tissue disorder resulting from mutations in the TGFβ receptor genes TGFβR1 and TGFβR2.[25]

Marfan syndrome is an autosomal dominant disorder caused by mutations in the Fibrillin-1 gene encoding an extracellular matrix protein which constitutes an essential component of microfibrils, critical in formation of elastin. Engvall first isolated the protein from human fibroblast cell culture in 1986, demonstrated its function as a component of extracellular microfibrils and its widespread expression through connective tissue in many organ systems [26]. Early linkage studies of families with Marfan syndrome mapped the gene to 15q21.1 [27], surprising some investigators who suspected defects in the Elastin gene were causal. Subsequent mutational analysis of FBN1 in patients with Marfan system revealed identical missense mutations in two unrelated patients9. Many linkage studies have been performed and demonstrate that most families have private mutations. The FBN1 gene is very large, consisting of 65 exons. It encodes a 350 kiloDalton protein and is highly conserved between different species.

Familial mutations of the FBN1 gene account for 75% of cases of Marfan syndrome and their corresponding phenotype is inherited in a dominant fashion. Over 500 different FBN1 mutations have been detected in Marfan syndrome patients [28]. 56% of these mutations are missense mutations, most often by creating or substituting a cysteine in a cbEGF domain critical for calcium binding [29]. Missense mutations are clustered in loci with cbEGF domains and typically cause moderate to severe phenotype [30]. Other documented mutations include nonsense, frameshift and splice site mutations. Complete deletions of a FBN1 allele are very rare. 90% of FBN1 mutations are private to an individual or family10. The incredibly diverse set of mutations that cause the syndrome suggest that these mutations generally reflect loss-of-function cause a dominant negative phenotype. Haploinsufficiency and other theories have been proposed to account for the dominant negative phenomenon which will be detailed later.

No FBN1 mutation can be identified in 10% of Marfan syndrome patients [31]. In this subset of patients, mutations in the transforming growth factor-beta receptor 2 (TGFBR2) are causal. Families with TGFBR2 mutations display autosomal dominant inheritance with variable penetrance.

Gross Pathology

On gross pathology, pneumothorax has the following findings:[32][33]

  • Pleuropulmonary adhesions
Bleb Source:By Robertolyra (Own work), via Wikimedia Commons


Microscopic Pathology

Lung Bleb Source:By Nephron (Own work) [CC BY-SA 4.0 via Wikimedia Commons


References

  1. Grundy S, Bentley A, Tschopp JM (2012). "Primary spontaneous pneumothorax: a diffuse disease of the pleura". Respiration. 83 (3): 185–9. doi:10.1159/000335993. PMID https://www.ncbi.nlm.nih.gov/pubmed/22343477 Check |pmid= value (help).
  2. Lee SC, Cheng YL, Huang CW, Tzao C, Hsu HH, Chang H (2008). "Simultaneous bilateral primary spontaneous pneumothorax". Respirology. 13 (1): 145–8. doi:10.1111/j.1440-1843.2007.01168.x. PMID 18197926.
  3. Bintcliffe, O.; Maskell, N. (2014). "Spontaneous pneumothorax". BMJ. 348 (may08 1): g2928–g2928. doi:10.1136/bmj.g2928. ISSN 1756-1833.
  4. Tschopp JM, Rami-Porta R, Noppen M, Astoul P (2006). "Management of spontaneous pneumothorax: state of the art". Eur Respir J. 28 (3): 637–50. doi:10.1183/09031936.06.00014206. PMID 16946095.
  5. Grundy, Seamus; Bentley, Andrew; Tschopp, Jean-Marie (2012). "Primary Spontaneous Pneumothorax: A Diffuse Disease of the Pleura". Respiration. 83 (3): 185–189. doi:10.1159/000335993. ISSN 1423-0356.
  6. Barton ED, Rhee P, Hutton KC, Rosen P (1997). "The pathophysiology of tension pneumothorax in ventilated swine". J Emerg Med. 15 (2): 147–53. PMID 9144053.
  7. Yazkan R, Han S (2010). "Pathophysiology, clinical evaluation and treatment options of spontaneous pneumothorax". Tuberk Toraks. 58 (3): 334–43. PMID 21038147.
  8. Nelson D, Porta C, Satterly S, Blair K, Johnson E, Inaba K; et al. (2013). "Physiology and cardiovascular effect of severe tension pneumothorax in a porcine model". J Surg Res. 184 (1): 450–7. doi:10.1016/j.jss.2013.05.057. PMID 23764307.
  9. Plewa MC, Ledrick D, Sferra JJ (1995). "Delayed tension pneumothorax complicating central venous catheterization and positive pressure ventilation". Am J Emerg Med. 13 (5): 532–5. PMID 7662057.
  10. Kornbau C, Lee KC, Hughes GD, Firstenberg MS (2015). "Central line complications". Int J Crit Illn Inj Sci. 5 (3): 170–8. doi:10.4103/2229-5151.164940. PMC 4613416. PMID 26557487.
  11. Peuker E (2004). "Case report of tension pneumothorax related to acupuncture". Acupunct Med. 22 (1): 40–3. PMID 15077937.
  12. Kumar M, Singh A, Sidhu KS, Kaur A (2016). "Malposition of Subclavian Venous Catheter Leading to Chest Complications". J Clin Diagn Res. 10 (5): PD16–8. doi:10.7860/JCDR/2016/19399.7860. PMC 4948479. PMID 27437303.
  13. Juss JK, Speed CA, Warrington J, Mahadeva R (2008). "Acupuncture induced pneumothorax - a case report". Acupunct Med. 26 (3): 193–6. PMID 18818566.
  14. Ramnarain D, Braams R (2002). "[Bilateral pneumothorax in a young woman after acupuncture]". Ned Tijdschr Geneeskd. 146 (4): 172–5. PMID 11845568.
  15. Chiu HT, Garcia CK (2006). "Familial spontaneous pneumothorax". Curr Opin Pulm Med. 12 (4): 268–72. doi:10.1097/01.mcp.0000230630.73139.f0. PMID 16825879.
  16. Bintcliffe O, Maskell N (2014). "Spontaneous pneumothorax". BMJ. 348: g2928. doi:10.1136/bmj.g2928. PMID 24812003.
  17. Wakai A (2008). "Spontaneous pneumothorax". BMJ Clin Evid. 2008. PMC 2907964. PMID 19450320.
  18. Wakai AP (2011). "Spontaneous pneumothorax". BMJ Clin Evid. 2011. PMC 3275306. PMID 21477390.
  19. Andrivet P, Djedaini K, Teboul JL, Brochard L, Dreyfuss D (1995). "Spontaneous pneumothorax. Comparison of thoracic drainage vs immediate or delayed needle aspiration". Chest. 108 (2): 335–9. PMID 7634863.
  20. Lippert HL, Lund O, Blegvad S, Larsen HV (1991). "Independent risk factors for cumulative recurrence rate after first spontaneous pneumothorax". Eur Respir J. 4 (3): 324–31. PMID 1864347.
  21. Graham RB, Nolasco M, Peterlin B, Garcia CK (2005). "Nonsense mutations in folliculin presenting as isolated familial spontaneous pneumothorax in adults". Am J Respir Crit Care Med. 172 (1): 39–44. doi:10.1164/rccm.200501-143OC. PMID 15805188.
  22. Ray A, Gupta M (2017). "Iatrogenic buffalo-chest syndrome". Indian J Radiol Imaging. 27 (2): 254–255. doi:10.4103/0971-3026.209202. PMC 5510326. PMID 28744089.
  23. Reading M (2015). "Bilateral pneumothoraces secondary to a Buffalo chest". Aust Crit Care. 28 (1): 10, discussion 54-5. PMID 25879087.
  24. Entrez Gene (2007). "TGFBR2 transforming growth factor, beta receptor II" (Entrez gene entry). NCBI.
  25. "Related Disorders: Loeys-Dietz". National Marfan Foundation.
  26. Sakai LY, Keene DR, Engvall E (1986). "Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils". The Journal of Cell Biology. 103 (6 Pt 1): 2499–509. PMC 2114568. PMID 3536967. Retrieved 2010-12-22. Unknown parameter |month= ignored (help)
  27. Kainulainen K, Pulkkinen L, Savolainen A, Kaitila I, Peltonen L (1990). "Location on chromosome 15 of the gene defect causing Marfan syndrome". The New England Journal of Medicine. 323 (14): 935–9. doi:10.1056/NEJM199010043231402. PMID 2402262. Retrieved 2010-12-22. Unknown parameter |month= ignored (help)
  28. Collod-Béroud G, Béroud C, Ades L, Black C, Boxer M, Brock DJ, Holman KJ, de Paepe A, Francke U, Grau U, Hayward C, Klein HG, Liu W, Nuytinck L, Peltonen L, Alvarez Perez AB, Rantamäki T, Junien C, Boileau C (1998). "Marfan Database (third edition): new mutations and new routines for the software". Nucleic Acids Research. 26 (1): 229–3. PMC 147226. PMID 9399842. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  29. Hilhorst-Hofstee Y, Hamel BC, Verheij JB, Rijlaarsdam ME, Mancini GM, Cobben JM, Giroth C, Ruivenkamp CA, Hansson KB, Timmermans J, Moll HA, Breuning MH, Pals G (2010). "The clinical spectrum of complete FBN1 allele deletions". European Journal of Human Genetics : EJHG. doi:10.1038/ejhg.2010.174. PMID 21063442. Retrieved 2010-12-22. Unknown parameter |month= ignored (help)
  30. Dietz HC, McIntosh I, Sakai LY, Corson GM, Chalberg SC, Pyeritz RE, Francomano CA (1993). "Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome". Genomics. 17 (2): 468–75. doi:10.1006/geno.1993.1349. PMID 8406497. Retrieved 2010-12-22. Unknown parameter |month= ignored (help)
  31. Michael J Wright HMC. Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders. In: UptoDate; 2010.
  32. Khan, Omar A.; Tsang, Geoffrey M.; Barlow, Clifford W.; Amer, Khalid M. (2006). "Routine Histological Analysis of Resected Lung Tissue in Primary Spontaneous Pneumothorax—Is It Justified?". Heart, Lung and Circulation. 15 (2): 137–138. doi:10.1016/j.hlc.2005.10.007. ISSN 1443-9506.
  33. Schneider, Frank; Murali, Rajmohan; Veraldi, Kristen L.; Tazelaar, Henry D.; Leslie, Kevin O. (2014). "Approach to Lung Biopsies From Patients With Pneumothorax". Archives of Pathology & Laboratory Medicine. 138 (2): 257–265. doi:10.5858/arpa.2013-0091-RA. ISSN 0003-9985.
  34. Ayed, Adel K.; Chandrasekaran, Chezhian; Sukumar, Murugan (2006). "Video-assisted thoracoscopic surgery for primary spontaneous pneumothorax: clinicopathological correlation". European Journal of Cardio-Thoracic Surgery. 29 (2): 221–225. doi:10.1016/j.ejcts.2005.11.005. ISSN 1010-7940.

Template:WH Template:WS